Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 7, Pages 1901
Publisher
MDPI AG
Online
2020-07-14
DOI
10.3390/cancers12071901
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- POT1 mutation spectrum in tumour types commonly diagnosed among POT1-associated hereditary cancer syndrome families
- (2020) Erica Shen et al. JOURNAL OF MEDICAL GENETICS
- Pan-cancer analysis of whole genomes
- (2020) NATURE
- Genomic footprints of activated telomere maintenance mechanisms in cancer
- (2020) Lina Sieverling et al. Nature Communications
- The multifaceted role of reactive oxygen species in tumorigenesis
- (2020) Anuradha Kirtonia et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants
- (2020) Yi Gong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The Role of Alternative RNA Splicing in the Regulation of hTERT, Telomerase, and Telomeres: Implications for Cancer Therapeutics
- (2020) Aaron L. Slusher et al. Cancers
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment
- (2019) Pasquale Zizza et al. NUCLEIC ACIDS RESEARCH
- A virome-wide clonal integration analysis platform for discovering cancer viral etiology
- (2019) Xun Chen et al. GENOME RESEARCH
- Telomerase-Targeted Cancer Immunotherapy
- (2019) Eishiro Mizukoshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic impact of telomeric repeat-containing RNA expression on long-term oncologic outcomes in colorectal cancer
- (2019) Sung Uk Bae et al. MEDICINE
- A non-natural nucleotide uses a specific pocket to selectively inhibit telomerase activity
- (2019) Wilnelly Hernandez-Sanchez et al. PLOS BIOLOGY
- Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer
- (2019) Andrew T. Ludlow et al. Cancers
- A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
- (2019) Luis Teixeira et al. CLINICAL CANCER RESEARCH
- Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere
- (2019) Ming-Hao Hu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy
- (2019) Ekta Khattar et al. Nature Communications
- Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma
- (2018) Mary L. McMaster et al. BRITISH JOURNAL OF HAEMATOLOGY
- Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
- (2018) Chulwon Kim et al. CANCER LETTERS
- Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
- (2018) Thomas J. Mitchell et al. CELL
- Discovery of Novel Schizocommunin Derivatives as Telomeric G-Quadruplex Ligands That Trigger Telomere Dysfunction and the Deoxyribonucleic Acid (DNA) Damage Response
- (2018) Tong Che et al. JOURNAL OF MEDICINAL CHEMISTRY
- Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors
- (2018) Satarupa Sengupta et al. MOLECULAR CANCER THERAPEUTICS
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- GV1001 Induces Apoptosis by Reducing Angiogenesis in Renal Cell Carcinoma Cells Both In Vitro and In Vivo
- (2018) Ga Eun Kim et al. UROLOGY
- Telomerase-Mediated Strategy for Overcoming Non–Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
- (2018) Ilgen Mender et al. NEOPLASIA
- Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1
- (2018) Xueyong Xu et al. Nature Communications
- NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer
- (2018) Andrew T. Ludlow et al. Nature Communications
- Improving TCR affinity on 293 T cells
- (2018) Rieko Ohta et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A mechanistic classification of clinical phenotypes in neuroblastoma
- (2018) Sandra Ackermann et al. SCIENCE
- Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma
- (2017) Kai-Ping Chang et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Telomerase Inhibitors from Natural Products and Their Anticancer Potential
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
- (2017) Shikhar Mehrotra et al. Journal of Hematology & Oncology
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Systematic analysis of telomere length and somatic alterations in 31 cancer types
- (2017) Floris P Barthel et al. NATURE GENETICS
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme
- (2017) Da Eun Jeong et al. Oncology Letters
- CTCF driven TERRA transcription facilitates completion of telomere DNA replication
- (2017) Kate Beishline et al. Nature Communications
- Chiral platinum (II)-4-(2,3-dihydroxypropyl)- formamide oxo-aporphine (FOA) complexes promote tumor cells apoptosis by directly targeting G-quadruplex DNA in vitro and in vivo
- (2017) Qi-Pin Qin et al. Oncotarget
- Expression of Telomere Repeat Binding Factor 1 and TRF2 in Prostate Cancer and Correlation with Clinical Parameters
- (2017) Wei Chen et al. Biomed Research International
- Platinum(II) phenanthroimidazole G-quadruplex ligand induces selective telomere shortening in A549 cancer cells
- (2016) Johanna Mancini et al. BIOCHIMIE
- Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia
- (2016) H. E. Speedy et al. BLOOD
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies
- (2016) Mohammad K Islam et al. Future Medicinal Chemistry
- TERTpromoter mutations in melanoma survival
- (2016) Eduardo Nagore et al. INTERNATIONAL JOURNAL OF CANCER
- Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression
- (2016) Ekta Khattar et al. JOURNAL OF CLINICAL INVESTIGATION
- Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, andTERTpromoter hotspot mutations andTERTgene amplification as likely drivers of progression
- (2016) Salvatore Piscuoglio et al. JOURNAL OF PATHOLOGY
- TRF2-Mediated Control of Telomere DNA Topology as a Mechanism for Chromosome-End Protection
- (2016) Delphine Benarroch-Popivker et al. MOLECULAR CELL
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor
- (2016) Ning Liu et al. NUCLEIC ACIDS RESEARCH
- HighTERTpromoter mutation frequency in non-acral cutaneous metastatic melanoma
- (2016) Henrik Ekedahl et al. Pigment Cell & Melanoma Research
- Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer
- (2016) Daniel Chubb et al. Nature Communications
- Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation
- (2016) S. C. Ak nc lar et al. Cancer Discovery
- Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner
- (2016) Robin E. Frink et al. Oncotarget
- Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma
- (2016) Na Wang et al. Oncotarget
- Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis
- (2016) Alexandra M. Pinzaru et al. Cell Reports
- Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
- (2016) Mohammad A. Jafri et al. Genome Medicine
- Regulation of the Human Telomerase Gene TERT by Telomere Position Effect—Over Long Distances (TPE-OLD): Implications for Aging and Cancer
- (2016) Wanil Kim et al. PLOS BIOLOGY
- T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy
- (2016) Jon Amund Kyte et al. OncoImmunology
- mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
- (2016) Troels Holz Borch et al. OncoImmunology
- Nuclear respiratory factor 1 and endurance exercise promote human telomere transcription
- (2016) A. Diman et al. Science Advances
- Synthesis and antiproliferative activity of 2,7-diamino l0-(3,5-dimethoxy)benzyl-9(10H)-acridone derivatives as potent telomeric G-quadruplex DNA ligands
- (2015) Chunmei Gao et al. BIOORGANIC CHEMISTRY
- The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells
- (2015) Jillian E. Koziel et al. BREAST CANCER RESEARCH AND TREATMENT
- Immunological features of T cells induced by human telomerase reverse transcriptase-derived peptides in patients with hepatocellular carcinoma
- (2015) Eishiro Mizukoshi et al. CANCER LETTERS
- Chromothripsis and Kataegis Induced by Telomere Crisis
- (2015) John Maciejowski et al. CELL
- Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damage
- (2015) M. Garcia-Beccaria et al. EMBO Molecular Medicine
- Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
- (2015) Dong-Sheng Huang et al. EUROPEAN JOURNAL OF CANCER
- Quantitative assessment of telomerase components in cancer cell lines
- (2015) Semih Can Akıncılar et al. FEBS LETTERS
- Mutation of theTERTpromoter, switch to active chromatin, and monoallelicTERTexpression in multiple cancers
- (2015) Josh Lewis Stern et al. GENES & DEVELOPMENT
- Human telomerase: biogenesis, trafficking, recruitment, and activation
- (2015) Jens C. Schmidt et al. GENES & DEVELOPMENT
- Immunotherapy of tumors with human telomerase reverse transcriptase immortalized human umbilical vein endothelial cells
- (2015) XIYAN MU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity
- (2015) Cheryl M. Koh et al. JOURNAL OF CLINICAL INVESTIGATION
- Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Tumor Cell Apoptosis by Organoplatinum(II) Complexes with Oxoisoaporphine
- (2015) Zhen-Feng Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells
- (2015) Resham Lal Gurung et al. Journal of Nutrigenetics and Nutrigenomics
- TRF2 Recruits RTEL1 to Telomeres in S Phase to Promote T-Loop Unwinding
- (2015) Grzegorz Sarek et al. MOLECULAR CELL
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
- (2015) Yinghui Li et al. NATURE CELL BIOLOGY
- TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
- (2015) Linda J Valentijn et al. NATURE GENETICS
- Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
- (2015) Jean-Charles Nault et al. NATURE GENETICS
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Rap1 modulates TRF2 attraction to telomeric DNA
- (2015) Eliška Janoušková et al. NUCLEIC ACIDS RESEARCH
- Telomere elongation chooses TERRA ALTernatives
- (2015) Rajika Arora et al. RNA Biology
- TERTpromoter mutations and telomerase reactivation in urothelial cancer
- (2015) Sumit Borah et al. SCIENCE
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway
- (2015) Ahmad Fatemi et al. TUMOR BIOLOGY
- A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families
- (2015) Oriol Calvete et al. Nature Communications
- TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
- (2015) Barbara Heidenreich et al. Oncotarget
- Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one
- (2015) Daniela Fenoglio et al. Human Vaccines & Immunotherapeutics
- The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres
- (2015) Amanda K. Frank et al. PLoS Genetics
- Cancer-associated TERT promoter mutations abrogate telomerase silencing
- (2015) Kunitoshi Chiba et al. eLife
- Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response
- (2015) Jessie Thalmensi et al. OncoImmunology
- Over-Expression of Telomere Binding Factors (TRF1 & TRF2) in Renal Cell Carcinoma and Their Inhibition by Using SiRNA Induce Apoptosis, Reduce Cell Proliferation and Migration Invitro
- (2015) Deeksha Pal et al. PLoS One
- TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
- (2015) Hong Xie et al. Oncotarget
- DNA vaccine for cancer immunotherapy
- (2015) Benjamin Yang et al. Human Vaccines & Immunotherapeutics
- TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer
- (2014) Flavio Salazar-Onfray et al. BIOLOGICAL RESEARCH
- Tumor-suppressive effect of a telomerase-derived peptide by inhibiting hypoxia-induced HIF-1α-VEGF signaling axis
- (2014) Bu-Kyung Kim et al. BIOMATERIALS
- The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells
- (2014) J. Zhang et al. BLOOD
- TERTpromoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA
- (2014) Na Wang et al. CANCER
- Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
- (2014) Katherine A. Hoadley et al. CELL
- TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1/POT1 repressor of ATR signaling
- (2014) Michal Zimmermann et al. GENES & DEVELOPMENT
- Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients
- (2014) CAROLINE STAFF et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity
- (2014) Jie Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- DEAD-box helicase DP103 defines metastatic potential of human breast cancers
- (2014) Eun Myoung Shin et al. JOURNAL OF CLINICAL INVESTIGATION
- BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
- (2014) Mingzhao Xing et al. JOURNAL OF CLINICAL ONCOLOGY
- A primary melanoma and its asynchronous metastasis highlight the role ofBRAF,CDKN2A, andTERT
- (2014) Gregory A. Hosler et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Germline Mutations in Shelterin Complex Genes Are Associated With Familial Glioma
- (2014) Matthew N. Bainbridge et al. JNCI-Journal of the National Cancer Institute
- Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma
- (2014) Lauren G. Aoude et al. JNCI-Journal of the National Cancer Institute
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- (2014) Gary Middleton et al. LANCET ONCOLOGY
- A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide
- (2014) Athanasios Kotsakis et al. LUNG CANCER
- POT1 loss-of-function variants predispose to familial melanoma
- (2014) Carla Daniela Robles-Espinoza et al. NATURE GENETICS
- Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types
- (2014) Nils J Fredriksson et al. NATURE GENETICS
- Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
- (2014) Jianxin Shi et al. NATURE GENETICS
- Telomerase stimulates ribosomal DNA transcription under hyperproliferative conditions
- (2014) Omar Garcia Gonzalez et al. Nature Communications
- Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
- (2014) Barbara Heidenreich et al. Nature Communications
- Identification of TERRA locus unveils a telomere protection role through association to nearly all chromosomes
- (2014) Isabel López de Silanes et al. Nature Communications
- RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells
- (2014) Rajika Arora et al. Nature Communications
- Induction of Telomere Dysfunction Mediated by the Telomerase Substrate Precursor 6-Thio-2′-Deoxyguanosine
- (2014) Ilgen Mender et al. Cancer Discovery
- The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter
- (2014) Mounir El Maï et al. Cell Reports
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia
- (2013) Y. Miyazaki et al. BLOOD
- Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression
- (2013) Julieta Panero et al. BLOOD CELLS MOLECULES AND DISEASES
- A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer
- (2013) Daniela Fenoglio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
- (2013) I. Kinde et al. CANCER RESEARCH
- A Multicenter Randomized Phase IIb Efficacy Study of Vx-001, a Peptide-Based Cancer Vaccine as Maintenance Treatment in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics
- (2013) Vassilis Georgoulias et al. Clinical Lung Cancer
- TERT promoter mutations in cancer development
- (2013) Barbara Heidenreich et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging
- (2013) Edwin Leeansyah et al. JOURNAL OF INFECTIOUS DISEASES
- Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma
- (2013) Glynis A Scott et al. MODERN PATHOLOGY
- TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
- (2013) Annamaria Biroccio et al. NATURE CELL BIOLOGY
- POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia
- (2013) Andrew J Ramsay et al. NATURE GENETICS
- The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
- (2013) T Liu et al. ONCOGENE
- Targeting Human Telomeric G-Quadruplex DNA and Inhibition of Telomerase Activity With [(dmb)2Ru(obip)Ru(dmb)2]4+
- (2013) Shuo Shi et al. PLoS One
- TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
- (2013) P. S. Rachakonda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- RTEL1 Is a Replisome-Associated Helicase That Promotes Telomere and Genome-Wide Replication
- (2013) J.-B. Vannier et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Telomerase: central regulator of all of the hallmarks of cancer
- (2013) Kee Chung Low et al. TRENDS IN BIOCHEMICAL SCIENCES
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- Nontelomeric Role for Rap1 in Regulating Metabolism and Protecting against Obesity
- (2013) Frank Yeung et al. Cell Reports
- Highly Optimized DNA Vaccine Targeting Human Telomerase Reverse Transcriptase Stimulates Potent Antitumor Immunity
- (2013) J. Yan et al. Cancer Immunology Research
- Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks
- (2012) Xuping Wu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
- (2012) Tim F Greten et al. BMC CANCER
- Induction of senescence in cancer cells by the G-quadruplex stabilizer, BMVC4, is independent of its telomerase inhibitory activity
- (2012) Fong-Chun Huang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Telomere-Driven Tetraploidization Occurs in Human Cells Undergoing Crisis and Promotes Transformation of Mouse Cells
- (2012) Teresa Davoli et al. CANCER CELL
- Novel anticancer therapeutics targeting telomerase
- (2012) Maria Ruden et al. CANCER TREATMENT REVIEWS
- Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
- (2012) Jian Hu et al. CELL
- Telomeric 3′ Overhangs Derive from Resection by Exo1 and Apollo and Fill-In by POT1b-Associated CST
- (2012) Peng Wu et al. CELL
- Human Rap1 Interacts Directly with Telomeric DNA and Regulates TRF2 Localization at the Telomere
- (2012) N. Özlem Arat et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular characterization of chromosomal band 5p15.33: A recurrent breakpoint region in mantle cell lymphoma involving the TERT–CLPTM1L locus
- (2012) Georgia Schilling et al. LEUKEMIA RESEARCH
- Alternatively Spliced Telomerase Reverse Transcriptase Variants Lacking Telomerase Activity Stimulate Cell Proliferation
- (2012) R. Hrdlickova et al. MOLECULAR AND CELLULAR BIOLOGY
- Telomere Profiling: Toward Glioblastoma Personalized Medicine
- (2012) Sylvain Ferrandon et al. MOLECULAR NEUROBIOLOGY
- Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
- (2012) Wing-Kin Sung et al. NATURE GENETICS
- Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
- (2012) Else-Marit Inderberg-Suso et al. OncoImmunology
- Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study
- (2011) A. Kotsakis et al. ANNALS OF ONCOLOGY
- Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters
- (2011) Jinbo GAO et al. Asia-Pacific Journal of Clinical Oncology
- Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001
- (2011) Eleni-Kyriaki Vetsika et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
- (2011) Robert E. Hunger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human telomeric proteins occupy selective interstitial sites
- (2011) Dong Yang et al. CELL RESEARCH
- Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
- (2011) J. A. Kyte et al. CLINICAL CANCER RESEARCH
- Five dysfunctional telomeres predict onset of senescence in human cells
- (2011) Zeenia Kaul et al. EMBO REPORTS
- Telomere Protection by TPP1/POT1 Requires Tethering to TIN2
- (2011) Kaori K. Takai et al. MOLECULAR CELL
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies
- (2010) I. Nagel et al. BLOOD
- Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth
- (2010) Denis Drygin et al. CANCER RESEARCH
- The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
- (2010) I. Joseph et al. CANCER RESEARCH
- Persistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy
- (2010) Teresa Davoli et al. CELL
- ATR-X Syndrome Protein Targets Tandem Repeats and Influences Allele-Specific Expression in a Size-Dependent Manner
- (2010) Martin J. Law et al. CELL
- The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
- (2010) C. O. Marian et al. CLINICAL CANCER RESEARCH
- Structural Basis of Selective Ubiquitination of TRF1 by SCFFbx4
- (2010) Zhixiong Zeng et al. DEVELOPMENTAL CELL
- POT1–TPP1 enhances telomerase processivity by slowing primer dissociation and aiding translocation
- (2010) Chrysa M Latrick et al. EMBO JOURNAL
- Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers
- (2010) Jeremy D. Henson et al. FEBS LETTERS
- Functional interaction between telomere protein TPP1 and telomerase
- (2010) A. J. Zaug et al. GENES & DEVELOPMENT
- Telomerase-Based Therapies Emerging Slowly
- (2010) V. Brower JNCI-Journal of the National Cancer Institute
- Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
- (2010) Hsiangling Teo et al. NATURE CELL BIOLOGY
- Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites
- (2010) Paula Martinez et al. NATURE CELL BIOLOGY
- The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase
- (2010) Sophie Redon et al. NUCLEIC ACIDS RESEARCH
- Telomeric repeat-containing RNA structure in living cells
- (2010) Y. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of Rap1 Induces Telomere Recombination in the Absence of NHEJ or a DNA Damage Signal
- (2010) A. Sfeir et al. SCIENCE
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Mammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication
- (2009) Agnel Sfeir et al. CELL
- Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice
- (2009) P. Martinez et al. GENES & DEVELOPMENT
- Rearrangement of upstream sequences of thehTERTgene during cellular immortalization
- (2009) Yuanjun Zhao et al. GENES CHROMOSOMES & CANCER
- Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs
- (2009) Mark M Aloysius et al. Journal of Translational Medicine
- TRF1 Controls Telomere Length and Mitotic Fidelity in Epithelial Homeostasis
- (2009) P. Munoz et al. MOLECULAR AND CELLULAR BIOLOGY
- Flap Endonuclease 1 Contributes to Telomere Stability
- (2008) Abhishek Saharia et al. CURRENT BIOLOGY
- Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control
- (2008) M. Bellon et al. JNCI-Journal of the National Cancer Institute
- Functional Dissection of Human and Mouse POT1 Proteins
- (2008) W. Palm et al. MOLECULAR AND CELLULAR BIOLOGY
- Activities of human exonuclease 1 that promote cleavage of transcribed immunoglobulin switch regions
- (2008) A. C. Vallur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prospects and challenges of building a cancer vaccine targeting telomerase
- (2007) Robert H. Vonderheide BIOCHIMIE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation